Steris PLC (STE)
| Market Cap | 22.40B |
| Revenue (ttm) | 3.41B |
| Net Income (ttm) | 287.40M |
| Shares Out | 99.76M |
| EPS (ttm) | 3.28 |
| PE Ratio | 68.67 |
| Forward PE | 34.25 |
| Dividend | $1.60 (0.71%) |
| Ex-Dividend Date | Sep 2, 2021 |
| Volume | 340,469 |
| Open | 225.13 |
| Previous Close | 224.19 |
| Day's Range | 222.75 - 225.66 |
| 52-Week Range | 169.67 - 225.66 |
| Beta | 0.57 |
| Analysts | Buy |
| Price Target | 249.60 (+10.9%) |
| Est. Earnings Date | Nov 8, 2021 |
About STE
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solut...
Financial Performance
In 2020, Steris's revenue was $3.11 billion, an increase of 2.53% compared to the previous year's $3.03 billion. Earnings were $397.40 million, a decrease of -2.52%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for Steris stock is "Buy." The 12-month stock price forecast is 249.60, which is an increase of 10.89% from the latest price.
News
Here's Why You Should Add STERIS (STE) to Your Portfolio
Investors are optimistic about STERIS (STE) owing to elevated consumer demand and rebound in procedure volumes and raised 2022 outlook.
2 Top Healthcare Stocks to Buy for the Long Haul
Their enduring appeal is nothing to pass over.
Steris (STE) Upgraded to Buy: What Does It Mean for the Stock?
Steris (STE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Steris (STE) Down 1.5% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Add STERIS (STE) to Your Portfolio Now
STERIS (STE) ended first-quarter fiscal 2022 with better-than-expected results and strong segmental performance, driving the top line.
STERIS (STE) Q1 Earnings Beat Estimates, 2022 Guidance Up
STERIS (STE) reported better-than-expected revenues for first-quarter fiscal 2022 on strong segmental performance driving the top line.
Steris (STE) Q1 Earnings and Revenues Top Estimates
Steris (STE) delivered earnings and revenue surprises of 17.33% and 7.07%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
STERIS Announces Financial Results for Fiscal 2022 First Quarter
DUBLIN, IRELAND, Aug. 09, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 first quarter ended June 30, 2021. Revenue as ...
5 Top Buy-Rated Stocks With Dividend Hikes Expected This Week
After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends that help to provide an income stream.
STERIS (STE) to Report Q1 Earnings: What's in the Cards?
Acquisitions of Cantel Medical and Key Surgical are expected to have contributed significantly to STERIS' (STE) first-quarter revenues.
STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021
DUBLIN, IRELAND , July 27, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 first quarter financ...
Steris (STE) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add STERIS (STE) to Your Portfolio
Investors are optimistic about STERIS (STE) owing to strong segmental performance and bullish 2022 outlook.
Five-Year Compounded Value of Steris Holdings
In a world obsessed with price movements of stocks, it's easy to lose sight of what those prices represent -- the value of holding a company's future profit potential. One of the key ways that profit po...
Steris (STE) Up 5% Since Last Earnings Report: Can It Continue?
Steris (STE) reported earnings 30 days ago. What's next for the stock?
STERIS (STE) Expands Product Suite With New Acquisition
STERIS' (STE) acquisition of Cantel Medical will complement and broaden the former's product and service offerings, global reach and customers.
STERIS Completes the Acquisition of Cantel Medical
DUBLIN, IRELAND, June 02, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of Cantel Medical, a glo...
Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600
NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO...
STERIS (STE) Q4 Earnings Fall Shy of Estimates, FY22 View Up
STERIS' (STE) fourth-quarter 2021 revenues improved year over year on robust growth across three segments.
Recap: Steris Q4 Earnings
Shares of Steris (NYSE:STE) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 0.61% over the past year to $1.63, which missed the estimat...
STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Year
DUBLIN, IRELAND, May 18, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 fourth quarter ended March 31, 2021. Revenue as...
STERIS (STE) to Report Q4 Earnings: What's in the Cards?
STERIS (STE) is likely to have continued to gain from the robust demand of PPE and COVID-19-related products in Q4.
STERIS Announces Changes to Board of Directors
DUBLIN, IRELAND, May 11, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced changes to its Board of Directors. David Lewis, Board member since 2010 has announced...
STERIS to Host a Conference Call for Fiscal 2021 Fourth Quarter and Full Year Financial Results on May 19, 2021
DUBLIN, IRELAND, April 27, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 fourth quarter and f...
STERIS (STE) Hits a New 52-Week High: What's Driving It?
Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.